To Increase Patient Access
End Brain Cancer Mobile App to download your number one tool for navigating this disease.

November 6, 2023

Why Jenn Ortiz Believes Her "Brain Cancer Has Been a Blessing" in Honor of Giving Tuesday

Giving Tuesday banner

Why Jenn Ortiz Believes Her Brain Cancer Has Been a Blessing

It was a day like any other day, until suddenly Jenn felt like she was choking on her tongue. She only had enough time to grab her husband's arm before she collapsed into a seizure. Soon after that, Jenn was diagnosed with an aggressive type of brain cancer known as Glioblastoma.

Jenn Ortiz photo

“When [Jenn] was first diagnosed with Glioblastoma and learned she may have only 12-15 months to live, she allowed one tear to roll down her cheek, then said, ‘No, not me,’” shared Jennifer Keeler, Ivy Center Communications Specialist. Jenn was determined to beat the tumor and she did. When the brain tumor returned two years later, she resolved to keep fighting and was able to beat it again.

Jenn and husband photo

Over 1,800 people like Jenn received guidance and support from the End Brain Cancer Initiative in 2022. It costs approximately $225 to help one patient gain access to life-saving treatments and resources. Reaching our goal of raising $25,000 for Giving Tuesday will help us provide support to over one hundred additional patients. Your generous donation to the End Brain Cancer Initiative will ensure that people like Jenn do not have to go through their cancer journey alone. Learn more about the End Brain Cancer Initiative at

Jenn believes her brain cancer has been a blessing. “I have been provided opportunities and time with my family I never had before. I’m home to take my young son to his activities… and I can make my mind, body, and soul a priority,” she said. Jenn provides hope to other brain cancer patients as a Patient Advocate with the End Brain Cancer Initiative.

By supporting the End Brain Cancer Initiative, you will help people like Jenn Ortiz survive this devastating disease. Donate today by clicking below.

Sponsor icons


Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
corporate partners
upcoming events
About us
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram